%20PLC/other/GRAFT_POLYMER_UK_PLC-logo.png){kind=logo}
GRAFT POLYMER (UK) PLC
Specializes in polymer modification for advanced materials and bio/pharma drug delivery systems.
GPL | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMD1Z199
- LEI:
- 2138005PH7OJRCRPUD88
- Country:
- United Kingdom
- Address:
- Eccleston Yards, SW1W 9NF London
- Website:
- https://graftpolymer.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of basic chemicals, fertilizers and nitrogen compounds, plastics and synthetic rubber in primary forms
Description
Graft Polymer is an innovative materials technology company specializing in polymer modification and the development of drug delivery systems. Its core business revolves around proprietary methods to combine incompatible polymers, creating high-performance alloys and compounds with enhanced mechanical, chemical, and fire-retardant properties. The company provides bespoke, "turn-key" solutions and customized products based on client requirements. Through its GraftBio division, launched in 2020, the company also develops intellectual property for bio/pharma applications, including biological supplements and advanced biopolymer drug delivery systems designed to improve the efficacy of therapeutics. The Group holds strong intellectual property and has filed several patent applications for its technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-31 16:59 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 7.7 KB | ||
| 2025-10-31 08:00 |
Share Issue/Capital Change
Corporate Structure Update and Issue of Options
|
English | 38.8 KB | ||
| 2025-10-16 08:00 |
Share Issue/Capital Change
Raises £1.25 Million to Accelerate Programmes
|
English | 13.3 KB | ||
| 2025-08-13 16:03 |
Regulatory Filings
Media Coverage: Small Cap Idea profile
|
English | 10.8 KB | ||
| 2025-08-12 08:00 |
Regulatory Filings
SVN-SDN-14 PTSD - Positive pre-clinical results
|
English | 11.3 KB | ||
| 2025-07-31 17:30 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 9.9 KB | ||
| 2025-07-22 08:00 |
Regulatory Filings
Translational Bridging Studies
|
English | 11.8 KB | ||
| 2025-07-18 12:03 |
Share Issue/Capital Change
Exercise of warrants
|
English | 9.0 KB | ||
| 2025-07-11 08:00 |
Share Issue/Capital Change
£1m subscription to accelerate AI drug discovery
|
English | 12.5 KB | ||
| 2025-06-27 15:38 |
AGM Information
AGM Statement
|
English | 22.1 KB | ||
| 2025-06-27 09:54 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.8 KB | ||
| 2025-06-26 11:21 |
Regulatory Filings
Initiation of Research Coverage
|
English | 10.4 KB | ||
| 2025-06-23 08:00 |
Regulatory Filings
Allowance of U.S. patent covering AI-supported CNS
|
English | 10.8 KB | ||
| 2025-06-11 08:30 |
Business and Financial Review
Initiation of AI supported CNS drug discovery
|
English | 10.8 KB | ||
| 2025-06-05 08:00 |
Environmental & Social Information
Synthesis of development candidate for SVN-SDN-014
|
English | 11.2 KB |
Automate Your Workflow. Get a real-time feed of all GRAFT POLYMER (UK) PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GRAFT POLYMER (UK) PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GRAFT POLYMER (UK) PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
